Epidemiological study of penile cancer in a northeastern state - Brazil.
Journal
Revista do Colegio Brasileiro de Cirurgioes
ISSN: 1809-4546
Titre abrégé: Rev Col Bras Cir
Pays: Brazil
ID NLM: 7809515
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
05
2023
accepted:
31
07
2023
medline:
20
11
2023
pubmed:
17
11
2023
entrez:
16
11
2023
Statut:
epublish
Résumé
to trace the clinical and epidemiological profile of penile cancer in Rio Grande do Norte/Brazil and relate them to data published in the literature. a cross-sectional study was conducted with 94 patients diagnosed with penile cancer in 2011-2018, treated at the Liga Norte Riograndense Contra o Cancer. all patients were diagnosed with squamous cell carcinoma, mainly aged over 50 years, from the states interior, brown, illiterate, or with incomplete primary education. At diagnosis, 68% of patients were classified as having tumors =T2, and 30% had lymph node involvement. Distant metastases were detected in 2.1% of patients at diagnosis. Most patients received the diagnosis in the initial phase of the disease, but 20.2% were diagnosed in stage IV. Partial penectomy was the most performed surgery, and 10% of patients relapsed, mainly in the lymph nodes (87.5%). The mean follow-up of the patients was 18 months, with an estimated overall survival at five years of 59.1%. However, 25% of patients were followed up for up to 3 months, losing follow-up. the State of Rio Grande do Norte has a high incidence of penile cancer with a high frequency of locally advanced tumors at diagnosis and in younger patients younger than 50. Furthermore, socioeconomic factors interfere with early diagnosis and hinder access to specialized services.
Identifiants
pubmed: 37971116
pii: S0100-69912023000100239
doi: 10.1590/0100-6991e-20233586-en
pmc: PMC10626489
pii:
doi:
Types de publication
Journal Article
Langues
eng
por
Sous-ensembles de citation
IM
Pagination
e20233586Références
J Urol. 2017 Dec;198(6):1346-1352
pubmed: 28652123
BJU Int. 2001 Sep;88(5):473-83
pubmed: 11589660
BMC Urol. 2018 May 29;18(1):50
pubmed: 29843769
Int Braz J Urol. 2008 Sep-Oct;34(5):587-91; discussion 591-3
pubmed: 18986562
PLoS One. 2022 Sep 22;17(9):e0274914
pubmed: 36137121
Int Braz J Urol. 2014 Nov-Dec;40(6):738-44
pubmed: 25615242
J Cancer Res Clin Oncol. 2020 Dec;146(12):3281-3296
pubmed: 33104884
Rev Panam Salud Publica. 2017 Nov 30;41:e117
pubmed: 31384255
Curr Probl Cancer. 2015 May-Jun;39(3):166-72
pubmed: 25920379
Semin Oncol Nurs. 2022 Jun;38(3):151284
pubmed: 35577640
Clin Genitourin Cancer. 2014 Apr;12(2):138-42
pubmed: 24210829
Oncol Lett. 2015 Jul;10(1):85-92
pubmed: 26170981
Asian J Urol. 2022 Oct;9(4):460-466
pubmed: 36381591
Curr Probl Cancer. 2015 May-Jun;39(3):126-36
pubmed: 26076979
Eur Urol. 2004 Jul;46(1):1-8
pubmed: 15183542
Br J Cancer. 2013 Nov 12;109(10):2554-9
pubmed: 24169355
Cien Saude Colet. 2010 Jun;15 Suppl 1:1105-11
pubmed: 20640268
World J Urol. 2013 Aug;31(4):861-7
pubmed: 22116602
BMC Urol. 2009 Aug 08;9:8
pubmed: 19664235